MILLENNIUM MANAGEMENT LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1273087
NEW YORK, NY
Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,644,354
-$15,087,241 QoQ
Shares Held
319,812
-66.5% QoQ
Ownership
0.549%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 328 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Derivatives in HRMY
reported options exposure · as of Dec 31, 2025CallValue
$561,300
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. HRMY ranks #94 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in HRMY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,644,354 | 319,812 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $26,731,595 | 954,359 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,670,064 | 231,696 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $561,300 | 15,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $5,636,295 | 204,510 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $925,532 | 29,289 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $232,330 | 7,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $2,605,149 | 78,492 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $217,918 | 6,333 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,832,440 | 70,811 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,274,861 | 307,420 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,807,639 | 202,729 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $724,650 | 22,435 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,463,789 | 105,700 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $1,664,716 | 50,800 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $2,150,109 | 61,100 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $17,186,796 | 488,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,464,994 | 443,032 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $1,306,000 | 40,000 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $771,400 | 14,000 | Put | Sole | 2023-02-14 | |
| 2022-12-31 | $9,528,443 | 172,930 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,238,082 | 27,954 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $714,327 | 14,683 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $440,428 | 10,329 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,056,864 | 53,662 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,204,096 | 148,923 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $252,855 | 7,653 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,229,567 | 144,663 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,044,329 | 414,287 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||